Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.

The Journal of Dermatological Treatment
Kristian ReichJonathan I Silverberg

Abstract

Itch, skin pain, and sleep disturbance are burdensome symptoms in atopic dermatitis (AD) that negatively influence a patient's quality of life (QoL). To evaluate the impact of baricitinib on patient-reported outcomes (PROs) in adult patients with moderate-to-severe AD, and explore the association between improvement in key signs and symptoms of AD with improvements in QoL and patient's assessment of disease severity. Data were analyzed from two phase III monotherapy trials (BREEZE-AD1/BREEZE-AD2) in which patients were randomized 2:1:1:1 to once-daily placebo, baricitinib 1-mg, 2-mg, or 4-mg for 16 weeks and assessed using PRO measures. At week 16, baricitinib 4-mg and 2-mg significantly reduced itch severity (Itch Numeric Rating Scale (NRS) (BREEZE-AD1: percent change from baseline -36.6% and -29.4% vs. placebo (-12.0%), p≤.001 and p≤.05; BREEZE-AD2: -47.2% and -46.9% vs. placebo (-16.6%), p≤.001). Baricitinib significantly reduced SCORing AD (SCORAD) pruritus (4-mg in BREEZE-AD1 and 2-mg in BREEZE-AD2) and Patient Oriented Eczema Measure (POEM) itch (both doses). Improvements in skin pain severity and sleep disturbance were also observed. Improvements in AD symptoms showed higher correlations with patients' assessment of AD s...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·B KunzA Taïeb
Aug 14, 2003·Health and Quality of Life Outcomes·R Philip Snaith
Dec 1, 2009·Journal of the American Academy of Dermatology·Smitha GowdaSteven R Feldman
Jun 16, 2010·Annals of Dermatology·Thomas Bieber
Mar 19, 2011·Allergy·J-F StalderUNKNOWN PO-SCORAD Investigators Group
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Jan 13, 2012·European Journal of Dermatology : EJD·Antonio TorreloJesús Cuervo
May 25, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·D Chrostowska-PlakJ C Szepietowski
Jun 19, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Jonathan I Silverberg, Eric L Simpson
Oct 30, 2013·The Journal of Investigative Dermatology·Roderick J HayMohsen Naghavi
Dec 3, 2013·Journal of the American Academy of Dermatology·Lawrence F EichenfieldRobert Sidbury
Oct 6, 2014·The Journal of Allergy and Clinical Immunology·Jochen SchmittUNKNOWN HOME initiative collaborators
Jan 24, 2015·Dermatology : International Journal for Clinical and Investigative Dermatology·M K A BasraA Y Finlay
Sep 1, 2015·The Journal of Investigative Dermatology·Sherry H Yu, Jonathan I Silverberg
Jan 19, 2016·Journal of the American Academy of Dermatology·Eric L SimpsonVera Mastey
Mar 24, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Dec 3, 2016·Journal of the American Academy of Dermatology·April W ArmstrongAbby S Van Voorhees
Oct 12, 2017·Journal of the American Academy of Dermatology·Laurent EckertJoel M Gelfand
Oct 25, 2017·Advances in Experimental Medicine and Biology·Adewole S Adamson
Dec 11, 2017·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Paras P VakhariaJonathan I Silverberg
Jan 20, 2018·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·J Y LeeK Ahn
Apr 12, 2018·Anais Brasileiros De Dermatologia·Tamar HajarJon M Hanifin
Jun 8, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A WollenbergUNKNOWN European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allerg
Jul 22, 2018·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan I SilverbergZelma C Chiesa Fuxench
Aug 19, 2018·Journal of the American Academy of Dermatology·Amalie Thorsti Møller RønnstadJacob P Thyssen
Nov 8, 2018·Allergy and Asthma Proceedings·Brian Reed, Michael S Blaiss
Jan 1, 2019·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Janice Chung, Eric L Simpson
Jan 8, 2019·The Journal of Allergy and Clinical Immunology·Tali CzarnowickiEmma Guttman-Yassky
Jan 18, 2019·The Journal of Allergy and Clinical Immunology. in Practice·Jonathan I SilverbergEric L Simpson
Jun 23, 2019·The Journal of Allergy and Clinical Immunology. in Practice·Jonathan I SilverbergPeck Y Ong
Jul 18, 2019·Journal of Patient-reported Outcomes·Louise NewtonJonathan I Silverberg
Aug 28, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·L EicherA Wollenberg
Sep 27, 2019·The British Journal of Dermatology·J P ThyssenA Egeberg
Nov 24, 2019·The Medical Clinics of North America·Jonathan I Silverberg
Jan 1, 2018·Anais Brasileiros De Dermatologia·Tamar HajarJoão Renato Vianna Gontijo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.